<DOC>
	<DOCNO>NCT00622206</DOCNO>
	<brief_summary>Compare Pharmacokinetics ritonavir saquinavir ( use either Saquinavir /Ritonavir 1500/100 mg 1500/50 mg ) Evaluate short term tolerability , safety toxicity Evaluate relation RTV concentration level boost effect</brief_summary>
	<brief_title>Pharmacokinetics Low Dose Ritonavir</brief_title>
	<detailed_description>This study focus combination Saquinavir ( SQV ) RTV . Firstly , SQV widely use Thailand show adequate first second line antiretroviral agent . Secondly , reduce dose SQV ( 1600 mg OD ) proven generate adequate efficacy good pharmacokinetic parameter Thai population [ 5 , 6 ] . Now 500 mg tablet SQV become available , therefore 1500 mg OD dose interest study . A TDM comparison study SQV 1600 OD mg SQV1500 mg OD do ( Ananworanich et al , unpublished data ) show difference term drug concentration . The efficacy regimen show adequate described STACCATO cohort [ 7 ] . So consider safe use SQV 1500 mg OD study . It clear RTV concentration necessary obtain good level SQV . In study Autar et al [ 5 ] relation RTV level boost effect describe . Besides might well even boost level RTV contribute toxicity antiretroviral treatment.For instance , study perform healthy volunteer RTV 100 mg BID monotherapy , show significant increase total cholesterol , low-density lipoprotein ( LDL ) cholesterol triglyceride mark reduction high-density lipoprotein ( HDL ) [ 8 ] . This last finding confirm study Boyd et al ( submit ) Thai HIV-infected patient . Preliminary data HIVNAT 019 [ 9 ] suggests low boosting dosage still give adequate level PIs . In open label 4 arm study one arm contain Lopinavir/Ritonavir 266/66 mg bid together SQV 600 mg bid . Despite dose reduction PIs , adequate PK level obtain . Two arm ( 23 patient ) study use normal dose RTV ( 100 mg bid ) combination Lopinavir Saquinavir . Five maximal concentration ( Cmax ) therapeutic level RTV ( &gt; 2.1 mg/l ) . This finding support clinical experience . Therefore , look low dos RTV Thai population great interest A liquid formulation RTV 50 mg use , capsule available yet . The liquid formulation bioequivalence capsule use extensively time manufactory problem Norvir capsule . Because bad taste formulation PK sample collect one week , thereafter patient return old regimen . A dose reduction RTV great importance Thai population prevents unnecessary toxicity cost . If PK study turn adequate , efficacy study perform boost commonly use PI 's , like IDV Lopinavir , study .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Ritonavir</mesh_term>
	<mesh_term>Saquinavir</mesh_term>
	<criteria>Age &gt; 18 year Documented positive test HIV1 infection HIV RNA viral load 50 &lt; copy least 3 month Written inform consent On Saquinavir 1500 mg base HAART regimen least 3 month Pregnant lactating Use concomitant medication may interfere pharmacokinetics saquinavir/ritonavir Inability understand nature extent study procedure require ALT/ AST 5x upper limit Relevant history current condition , illness might interfere drug absorption , distribution , metabolism excretion .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2012</verification_date>
	<keyword>Pharmacokinetics</keyword>
	<keyword>ritonavir</keyword>
	<keyword>saquinavir</keyword>
	<keyword>safety toxicity</keyword>
	<keyword>treatment experience</keyword>
</DOC>